SARM1 and retinal degeneration: The objective of the study was to evaluate whether ablation of SARM1, a key component of the axon degeneration pathway, could protect against complex I deficiency, mitochondrial dysfunction and subsequent vision loss in a well-established chemically induced mouse model of retinal degeneration [44,45,46].